Medical Crossfire®: Expert Perspectives in Neurotrophic Keratitis – Updates in Optimal Treatment Strategies & Emphasizing Importance of Early Intervention

Released On
September 14, 2021

Expires On
September 14, 2022

Media Type

Completion Time
90 minutes


Eye Disorders

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Dompé U.S., Inc.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Nurses — 1.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation. For those seeking COPE credit on this topic, please click here for this program

Target Audience

This online educational activity is directed toward ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with NK.

Activity Overview

The Medical Crossfire™, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of neurotrophic keratitis (NK). This lively discussion will help place new developments into clinical context to help you optimize care for your patients with or at risk for this eye disease.

Learning Objectives

Upon completion of this activity, you should be better able to:

  • Explain the role of the trigeminal and corneal sensory nerves in the normal function of the cornea
  • Summarize the diseases and injuries that commonly cause NK
  • Apply appropriate testing strategies in support of a timely diagnosis of NK
  • Develop evidence-based treatment plans for patients with NK based on disease stage




Francis S. Mah, MD

Director of Cornea and External Disease
Co-Director, Refractive Surgery
Scripps Clinic Medical Group
La Jolla, CA




Preeya K. Gupta, MD

Medical Director, Triangle Eye Consultants
Chef Medical Adviser, Surface Opthalmics, Inc.
Co-Founder, Interventional Mindset
Durham, NC


Edward J. Holland, MD

Professor of Clinical Ophthalmology
University of Cincinnati
Director of Cornea Services
Cincinnati Eye Institute
Cincinnati, OH


Stephen C. Pflugfelder, MD

Professor, James and Margaret Elkins Chair
Director, Ocular Surface Center at the Cullen Eye Institute,
Department of Ophthalmology
Baylor College of Medicine
Houston, TX


Physician Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Disclosures of Conflicts of Interest

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Francis S. Mah, MD

  • Consultant: Allergan; Novartis; Ocular Science



Preeya K. Gupta, MD

  • Consultant: Alcon, Allergan, HanAll Biopharma, Johnson & Johnson Vision, Kala Pharmaceuticals, New World Medical, Novartis, Ocular Therapeutix, Oyster Point Pharma, Inc., Sight Sciences, Surface Ophthalmics, Inc., Sun Inc., Tear Lab Corporation, TissueTech, Inc., Zeiss International


Edward J. Holland, MD

  • Consultant: Chief Medical Adviser, Aurion Biotech, Inc., Dompé


Stephen C. Pflugfelder, MD

  • Grant/Research Support: Dompe; Consultant: Kala, Dompe, Novartis, Kowa, Senju Pharmaceutical Co, Ltd


PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit


  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.


Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.